BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28943129)

  • 1. Time-resolved in vivo dosimetry for source tracking in brachytherapy.
    Johansen JG; Rylander S; Buus S; Bentzen L; Hokland SB; Søndergaard CS; With AKM; Kertzscher G; Tanderup K
    Brachytherapy; 2018; 17(1):122-132. PubMed ID: 28943129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of an in vivo dosimetry-based source tracking method for afterloading brachytherapy - A phantom study.
    Jørgensen EB; Kertzscher G; Buus S; Bentzen L; Hokland SB; Rylander S; Tanderup K; Johansen JG
    Med Phys; 2021 May; 48(5):2614-2623. PubMed ID: 33655555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time in vivo dosimetry in high dose rate prostate brachytherapy.
    Mason J; Mamo A; Al-Qaisieh B; Henry AM; Bownes P
    Radiother Oncol; 2016 Aug; 120(2):333-8. PubMed ID: 27236248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiconductor real-time quality assurance dosimetry in brachytherapy.
    Carrara M; Cutajar D; Alnaghy S; Espinoza A; Romanyukha A; Presilla S; Tenconi C; Cerrotta A; Fallai C; Safavi-Naeini M; Petasecca M; Kejda A; Lerch M; Corde S; Jackson M; Howie A; Bucci J; Rosenfeld AB
    Brachytherapy; 2018; 17(1):133-145. PubMed ID: 28964727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a fingerprinting method for fast catheter identification in HDR brachytherapy in vivo dosimetry.
    Tho D; Bélanger C; Jørgensen EB; Tanguay J; Rosales HML; Beddar S; Johansen JG; Kertzscher G; Lavallée MC; Beaulieu L
    Brachytherapy; 2024; 23(2):165-172. PubMed ID: 38281894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
    Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
    Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D source tracking and error detection in HDR using two independent scintillator dosimetry systems.
    Linares Rosales HM; Johansen JG; Kertzscher G; Tanderup K; Beaulieu L; Beddar S
    Med Phys; 2021 May; 48(5):2095-2107. PubMed ID: 33222208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dwell time verification in brachytherapy based on time resolved in vivo dosimetry.
    Johansen JG; Kertzscher G; Jørgensen EB; Rylander S; Bentzen L; Hokland SB; Søndergaard CS; With AKM; Buus S; Tanderup K
    Phys Med; 2019 Apr; 60():156-161. PubMed ID: 31000077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-probe scintillator dosimeter for treatment verification in HDR-brachytherapy.
    Gonod M; Suarez MA; Avila CC; Karakhanyan V; Eustache C; Laskri S; Crouzilles J; Vinchant JF; Aubignac L; Grosjean T
    Med Phys; 2023 Nov; 50(11):7192-7202. PubMed ID: 37738612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy.
    Mason J; Henry A; Bownes P
    Radiother Oncol; 2020 Aug; 149():38-43. PubMed ID: 32387490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
    Andersen CE; Nielsen SK; Lindegaard JC; Tanderup K
    Med Phys; 2009 Nov; 36(11):5033-43. PubMed ID: 19994514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scintillation dosimeter with real-time positional tracking information for in vivo dosimetry error detection in HDR brachytherapy.
    Tho D; Lavallée MC; Beaulieu L
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14150. PubMed ID: 37731203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric performance of a multipoint plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate
    Linares Rosales HM; Archambault L; Beddar S; Beaulieu L
    Med Phys; 2020 Sep; 47(9):4477-4490. PubMed ID: 32443175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive error detection for HDR/PDR brachytherapy: guidance for decision making during real-time in vivo point dosimetry.
    Kertzscher G; Andersen CE; Tanderup K
    Med Phys; 2014 May; 41(5):052102. PubMed ID: 24784391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimeters.
    Poder J; Howie A; Brown R; Bucci J; Rosenfeld A; Enari K; Schreiber K; Carrara M; Bece A; Malouf D; Cutajar D
    Radiother Oncol; 2020 Oct; 151():273-279. PubMed ID: 32798597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy.
    Edmundson GK; Yan D; Martinez AA
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D dose reconstruction based on in vivo dosimetry for determining the dosimetric impact of geometric variations in high-dose-rate prostate brachytherapy.
    Jørgensen EB; Buus S; Bentzen L; Hokland SB; Rylander S; Kertzscher G; Beddar S; Tanderup K; Johansen JG
    Radiother Oncol; 2022 Jun; 171():62-68. PubMed ID: 35033604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy.
    Carrara M; Romanyukha A; Tenconi C; Mazzeo D; Cerrotta A; Borroni M; Cutajar D; Petasecca M; Lerch M; Bucci J; Richetti A; Presilla S; Fallai C; Gambarini G; Pignoli E; Rosenfeld A
    Phys Med; 2017 Sep; 41():5-12. PubMed ID: 28499627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.